Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA3 | P22001 | 3/20 | 0.50 |
| ▸ | SOAT1 | P35610 | 6/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | STAT1 | P42224 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | APAF1 | O14727 | 1/20 | 0.40 |
| ▸ | KCNH3 | Q9ULD8 | 1/20 | 0.40 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.40 |
| ▸ | SOAT2 | O75908 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1726143 | 0.85 | SOAT1 (0.55) | KCNA3SOAT1L3MBTL1ALDH1A1NPC1 | |
| SCHEMBL1926388 | 0.83 | KCNA3 (0.48) | KCNA3SOAT1L3MBTL1ALDH1A1NPC1 | |
| SCHEMBL12984564 | 0.80 | SOAT1 (0.53) | KCNA3SOAT1ALDH1A1APAF1KDM4E | |
| SCHEMBL9927894 | 0.79 | SOAT1 (0.51) | KCNA3SOAT1L3MBTL1ALDH1A1NPC1 | |
| SCHEMBL1926387 | 0.78 | L3MBTL1 (0.48) | SOAT1L3MBTL1ALDH1A1MAPTCNR1 | |
| SCHEMBL1724131 | 0.76 | L3MBTL1 (0.51) | SOAT1L3MBTL1ALDH1A1NPC1MAPT | |
| SCHEMBL1580117 | 0.74 | MEN1 (0.45) | KCNA3L3MBTL1ALDH1A1NPC1MAPT | |
| SCHEMBL11266453 | 0.74 | L3MBTL1 (0.54) | SOAT1L3MBTL1ALDH1A1MAPTCNR1 | |
| SCHEMBL8535750 | 0.74 | L3MBTL1 (0.54) | SOAT1L3MBTL1ALDH1A1MAPTCNR1 | |
| SCHEMBL11266466 | 0.74 | L3MBTL1 (0.54) | SOAT1L3MBTL1ALDH1A1MAPTCNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7534894-B2 | Biphenyloxy-acids | WYETH (US) | 2009-05-19 | — | — | US | disclosed |
| EP-1667959-A1 | BIPHENYLOXY-ACIDS | Wyeth (US) | 2006-06-14 | — | — | EP | disclosed |
| US-20060020003-A1 | Biphenyloxy-acids | WYETH (US) | 2006-01-26 | — | — | US | disclosed |
| WO-2005030702-A1 | BIPHENYLOXY-ACIDS | WYETH (US) | 2005-04-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060020003-A1 | Biphenyloxy-acids | AHR, ARNT, NR1H4 | KCNA3 4188/4885SOAT1 1672/4885L3MBTL1 1585/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.